Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Profit After Tax (2023 - 2025)

Historic Profit After Tax for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • SBC Medical Group Holdings' Profit After Tax rose 35275.98% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.3 million, marking a year-over-year decrease of 2046.16%. This contributed to the annual value of $46.7 million for FY2024, which is 1859.25% up from last year.
  • Latest data reveals that SBC Medical Group Holdings reported Profit After Tax of $12.8 million as of Q3 2025, which was up 35275.98% from $2.5 million recorded in Q2 2025.
  • SBC Medical Group Holdings' 5-year Profit After Tax high stood at $21.5 million for Q1 2025, and its period low was $196786.0 during Q2 2023.
  • Over the past 3 years, SBC Medical Group Holdings' median Profit After Tax value was $8.4 million (recorded in 2023), while the average stood at $9.7 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 933020.59% in 2024, then plummeted by 8675.33% in 2025.
  • Quarter analysis of 3 years shows SBC Medical Group Holdings' Profit After Tax stood at $14.3 million in 2023, then plummeted by 54.35% to $6.5 million in 2024, then surged by 95.99% to $12.8 million in 2025.
  • Its Profit After Tax stands at $12.8 million for Q3 2025, versus $2.5 million for Q2 2025 and $21.5 million for Q1 2025.